Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.

× No keyword cloud information.

20 in total

1. [Functional relations between pharmacokinetic properties and dosage of chemotherapeutic agents].

Authors: E KRUEGER-THIEMER
Journal: Klin Wochenschr Date: 1960-06-01

2. Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man: individual variability in the extent of allopurinol and nortriptyline inhibition of drug metabolism.

Authors: E S Vesell; G T Passananti; F E Greene; J G Page
Journal: Ann N Y Acad Sci Date: 1971-07-06 Impact factor: 5.691

3. Genetic control of nortriptyline kinetics in man: a study of relatives of propositi with high plasma concentrations.

Authors: M Asberg; D A Evans; F Sjöqvist
Journal: J Med Genet Date: 1971-06 Impact factor: 6.318

4. Plasma protein binding of tricyclic anti-depressants in man.

Authors: O Borgå; D L Azarnoff; G P Forshell; F Sjöqvist
Journal: Biochem Pharmacol Date: 1969-09 Impact factor: 5.858

5. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors: S Riegelman; J C Loo; M Rowland
Journal: J Pharm Sci Date: 1968-01 Impact factor: 3.534

6. Pharmacokinetics of accumulation.

Authors: J M van Rossum
Journal: J Pharm Sci Date: 1968-12 Impact factor: 3.534

7. A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man.

Authors: W Hammer; S Mårtens; F Sjöqvist
Journal: Clin Pharmacol Ther Date: 1969 Jan-Feb Impact factor: 6.875

8. Impairment of drug metabolism in man by allopurinol and nortriptyline.

Authors: E S Vesell; G T Passananti; F E Greene
Journal: N Engl J Med Date: 1970-12-31 Impact factor: 91.245

9. Blood levels of drug at the equilibrium state after multiple dosing.

Authors: J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal: Nature Date: 1965-09-18 Impact factor: 49.962

10. Correlation of subjective side effects with plasma concentrations of nortriptyline.

Authors: M Asberg; B Cronholm; F Sjöqvist; D Tuck
Journal: Br Med J Date: 1970-10-03

43 in total

1. Evaluation of truncated areas in the assessment of bioequivalence of immediate release formulations of drugs with long half-lives and of Cmax with different dissolution rates.

Authors: P Sathe; J Venitz; L Lesko
Journal: Pharm Res Date: 1999-06 Impact factor: 4.200

Review 2. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.

Authors: Leif Bertilsson; Marja-Liisa Dahl; Per Dalén; Ayman Al-Shurbaji
Journal: Br J Clin Pharmacol Date: 2002-02 Impact factor: 4.335

3. Steady-state plasma nortriptyline concentrations in epileptic patients.

Authors: R A Braithwaite; R J Flanagan; A Richens
Journal: Br J Clin Pharmacol Date: 1975-10 Impact factor: 4.335

4. 3-H-nortriptyline uptake and tissue-binding in vitro and its effect on 3-H-noradrenaline uptake.

Authors: B Hamberger; J R Tuck
Journal: Experientia Date: 1975-06-15

5. Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis.

Authors: M E Mooney; V I Reus; J Gorecki; S M Hall; G L Humfleet; R F Muñoz; K Delucchi
Journal: Clin Pharmacol Ther Date: 2007-08-08 Impact factor: 6.875

6. Assessment of the anticholinergic effects of antidepressants in a single-dose cross-over study of salivation and plasma levels.

Authors: L Clemmesen; P L Mikkelsen; H Lund; T G Bolwig; O J Rafaelsen
Journal: Psychopharmacology (Berl) Date: 1984 Impact factor: 4.530

Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.